| 6332 |
Centers for Disease Control and Prevention |
Html |
en |
Depression, diabetes, and chronic disease risk factors among US women of reproductive age. |
null |
| past diagnosis | 0.345208 |
| risk factors | 0.782652 |
| current minor depression | 0.253063 |
| mental health | 0.200241 |
| disease risk factors | 0.422651 |
| reproductive age | 0.274282 |
| depression status | 0.357977 |
| past depression diagnosis | 0.243468 |
|
| chronic conditions | 0.604642 |
| chronic disease risk | 0.478946 |
| chronic disease | 0.604057 |
| minor depression | 0.459815 |
| current depression | 0.335059 |
| depression | 0.925897 |
| current major depression | 0.212198 |
| major depression | 0.385793 |
|
CLICK HERE |
| 6983 |
Centers for Disease Control and Prevention |
Html |
en |
Global Health - Sierra Leone |
CDC began working in Sierra Leone in 2008 and supports laboratory and surveillance capacity building activities for HIV and other infectious diseases. |
| CDC Foundation | 0.537277 |
| U.S. CDC | 0.934353 |
| 2014-2015 Ebola response | 0.468765 |
| 5-year immunization plan | 0.390789 |
| infectious disease threats | 0.373142 |
| AIDS Relief | 0.383123 |
| antimicrobial resistance | 0.376909 |
| Emergency Operations Centers | 0.371439 |
| national public health | 0.55138 |
| extensive global health | 0.428695 |
| permanent CDC Country | 0.660504 |
| Emergency Plan | 0.390637 |
| standard operating procedures | 0.358404 |
| World Health Organization | 0.422964 |
| vaccine coverage data | 0.367658 |
| MoHS immunization activities | 0.438689 |
| emergency management | 0.37982 |
| public health emergencies | 0.414296 |
| national oral polio | 0.366406 |
| 5-year national laboratory | 0.395251 |
| Emergency Operations | 0.374957 |
| laboratory systems | 0.379283 |
| public health management | 0.445759 |
| Health Security Agenda | 0.562091 |
|
| public health information | 0.416784 |
| GHSA action packages | 0.36874 |
| largest outbreak response | 0.430187 |
| Global Health Security | 0.73615 |
| Epidemiology Training Program | 0.371533 |
| Sierra Leone | 0.814147 |
| U.S. President | 0.403089 |
| biometrics-based immunization tracking | 0.384314 |
| nationwide measles vaccine | 0.369103 |
| Infant mortality rate | 0.391838 |
| new laboratory tests | 0.374518 |
| highest number | 0.38021 |
| public health | 0.682214 |
| Health Security efforts | 0.431873 |
| World Health Statistics | 0.432591 |
| infection prevention | 0.369913 |
| Central Public Health | 0.421044 |
| flaccid paralysis review | 0.367846 |
| MoHS disease surveillance | 0.445655 |
| public health Emergency | 0.442879 |
| Relief building laboratory | 0.410229 |
| West Africa | 0.38017 |
| public health data | 0.417111 |
| CDC technical assistance | 0.613478 |
|
CLICK HERE |
| 7551 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: Histoplasmosis Outbreak Among Day Camp Attendees - Nebraska, June 2012 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| logistic regression model | 0.72839 |
| respiratory illness outbreaks | 0.795626 |
| respiratory illness cluster | 0.806283 |
| County Health Department | 0.780458 |
| Douglas County | 0.747162 |
| original MMWR paper | 0.731792 |
| U.S. Government Printing | 0.729282 |
| endemic areas | 0.748107 |
| Human Services | 0.803307 |
| common fungal infection | 0.746769 |
| test p-value | 0.745024 |
| MMWR HTML versions | 0.732749 |
| U.S. Department | 0.719179 |
| Douglas County Dept | 0.717716 |
| camp administrators | 0.699555 |
| dirt floors | 0.734013 |
| wilderness skill training | 0.726182 |
| Laboratory-confirmed histoplasmosis | 0.732033 |
| Bryan F. Buss | 0.722233 |
| picnic tables | 0.976993 |
| electronic PDF version | 0.728302 |
| Histoplasma capsulatum antigen | 0.766038 |
| recreation division | 0.733171 |
| Zoonotic Infectious Diseases | 0.721946 |
|
| histoplasmosis | 0.746493 |
| Benjamin J. Park | 0.725592 |
| campsites | 0.810189 |
| personal protective equipment | 0.732735 |
| Career Epidemiology Field | 0.723355 |
| potentially contaminated areas | 0.735795 |
| additional symptom | 0.738612 |
| probable infection source | 0.730191 |
| camp arrival | 0.704023 |
| separate Internet-based questionnaire | 0.734579 |
| camp counselor | 0.770558 |
| campsite assignments | 0.816981 |
| Public Health Preparedness | 0.736631 |
| bat droppings | 0.758994 |
| camp attendees | 0.753485 |
| case definition | 0.740323 |
| Cochran-Armitage test p-value | 0.735006 |
| referent group | 0.729925 |
| original paper copy | 0.72183 |
| exact test p-value | 0.739478 |
| camp activities | 0.82193 |
| bat guano | 0.892122 |
| Kristin Yeoman | 0.74041 |
|
CLICK HERE |
| 10395 |
Centers for Disease Control and Prevention |
Html |
en |
DHDSP Data Trends and Maps Indicator Categorizations'DHDSP'CDC |
DHDSP Data Trends and Maps Help |
| Cardiovascular Diseases | 0.844935 |
| Risk Factors | 0.792209 |
| main categories | 0.521361 |
| following priority areas | 0.905055 |
| ABCS | 0.297158 |
| number | 0.251086 |
| Priority Indicators | 0.941759 |
|
| priority indicator | 0.668559 |
| AHA | 0.288143 |
| Cardiovascular Health Metrics | 0.837426 |
| subcategories | 0.660988 |
| Healthy People | 0.491508 |
| Goals | 0.249955 |
| Risk Factors category | 0.759515 |
|
CLICK HERE |
| 11580 |
Centers for Disease Control and Prevention |
Html |
en |
NER - Peer-Reviewed Biomonitoring Articles | Environmental Phenols: Bisphenol A (BPA) |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 11949 |
Centers for Disease Control and Prevention |
Html |
en |
Signos y síntomas | Enfermedad del Ébola |
null |
| average | 0.293902 |
| exposure | 0.292279 |
| immune response | 0.489463 |
| People | 0.240303 |
|
| Ebola infection develop | 0.925362 |
| antibodies | 0.29025 |
| supportive clinical care | 0.690135 |
| Recovery | 0.240921 |
|
CLICK HERE |
| 12062 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | Prevalence and Reasons for Initiating Use of Electronic Cigarettes Among Adults in Montana, 2013 - CDC |
We used data from the 2013 Montana Adult Tobacco Survey to estimate the prevalence of electronic cigarette (e-cigarette) use and reasons for initiation among Montana adults. More than 1 in 10 (11.2%, 95% confidence interval [CI], 9.1%–13.2%) adults reported ever using e-cigarettes, and 1.3% (95% CI, 0.7%–1.9%) reported current use. Most respondents reported “trying something new” (64%) or “trying to quit or reduce cigarette use” (56%) as a reason for initiating use. Ongoing surveillance of these addictive products is needed. |
| older adult e-cigarette | 0.682942 |
| Montana adults | 0.887587 |
| electronic cigarette | 0.939182 |
| electronic cigarette users | 0.758696 |
| frequently reported reasons | 0.756359 |
| electronic cigarettes | 0.745437 |
| population-based telephone survey | 0.686319 |
| adult respondents | 0.67433 |
| Human Services | 0.946114 |
| Adult Tobacco Surveys | 0.704112 |
| landline telephone numbers | 0.6755 |
| cigarette smoking | 0.770637 |
| prevalence | 0.696118 |
| current cigarette smokers | 0.845102 |
| younger adult e-cigarette | 0.687146 |
| older e-cigarette users | 0.678226 |
| tobacco control programs | 0.674496 |
| Disease Control | 0.729906 |
| Youth Tobacco Survey | 0.682242 |
| cigarette sales | 0.705886 |
| Fewer respondents | 0.653989 |
| Adult Tobacco Survey | 0.97302 |
| cigarette consumption | 0.683318 |
| public health | 0.886258 |
|
| younger e-cigarette users | 0.682341 |
| Montana Adult Tobacco | 0.846416 |
| current e-cigarette users | 0.714128 |
| e-cigarette users | 0.88901 |
| health education strategies | 0.654743 |
| answered telephone calls | 0.657966 |
| prevention programs | 0.660198 |
| e-cigarettes | 0.826186 |
| Tob Control | 0.657419 |
| long-term health effects | 0.651538 |
| noninstitutionalized Montana adults | 0.716127 |
| tobacco products | 0.682608 |
| public health efforts | 0.689384 |
| Native e-cigarette users | 0.687553 |
| Nicotine Tob Res | 0.655266 |
| young adults | 0.713782 |
| Weighted prevalence estimates | 0.688967 |
| Public Health Service | 0.65813 |
| adult e-cigarette users | 0.77379 |
| Survey Research Organizations | 0.664129 |
| Electronic nicotine delivery | 0.653136 |
| cellular telephone respondents | 0.73371 |
| Montana Department | 0.708679 |
|
CLICK HERE |
| 12686 |
Centers for Disease Control and Prevention |
Video |
en |
Global Disease Detectives |
CDC global health leadership brings the world's leading public health experts to a Guatemala cave, where rabid bats threaten human health. Elsewhere, CDC community workers keep a health watch over Kenya's poor; while in China, CDC scientists protect babies from a mysterious outbreak. These examples of CDC at work in the world help protect America and all from disease threats that respect no borders.
Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at http://www.cdc.gov/cdctv/DiseaseDetectives |
| Global Disease Detectives | 0.934136 |
|
|
CLICK HERE |
| 15341 |
Centers for Disease Control and Prevention |
Image |
null |
Clean It Up, Swimmers |
null |
|
|
CLICK HERE |
| 15989 |
Centers for Disease Control and Prevention |
Html |
en |
Thank You, CDC Influenza Molecular Diagnostic Performance Evaluation Exercise Enrollment |
This website is intended to facilitate technical support for domestic U.S. and international public health and research institutions performing influenza laboratory surveillance and/or research. |
| Influenza Diagnostic Testing | 0.368017 |
| Flu Illness | 0.465741 |
| Flu Viruses | 0.578597 |
| Flu Vaccines | 0.718731 |
| U.S. Influenza Surveillance | 0.359587 |
| Vaccine Benefits | 0.27901 |
| Prevent Flu | 0.528704 |
| Influenza Testing Results | 0.406465 |
| Flu Good Health | 0.518459 |
| Influenza Viruses | 0.409303 |
| Seasonal Influenza Vaccine | 0.650023 |
| Quadrivalent Influenza Vaccine | 0.557727 |
| Intradermal Influenza | 0.318457 |
| Flu Adults | 0.479376 |
| Flu Activity | 0.465305 |
| Influenza Pandemic Virus | 0.374647 |
| Flu Vaccine | 0.897973 |
| (Flu) | 0.791257 |
| ) Vaccination | 0.578942 |
| Influenza Vaccines | 0.452865 |
| United States Flu | 0.499946 |
| Vaccine Safety Vaccine | 0.502287 |
| Antiviral Drugs Antiviral | 0.291442 |
| Influenza Viruses Types | 0.401434 |
| Flublok Seasonal Influenza | 0.382795 |
|
| Vaccination Flu Vaccination | 0.56543 |
| High-Dose Seasonal Influenza | 0.385031 |
| Control Influenza Transmission | 0.339302 |
| Flu Antiviral Drugs | 0.723605 |
| CDC International Flu | 0.511398 |
| CDC Influenza Molecular | 0.488287 |
| Distribution Vaccine Supply | 0.301129 |
| Prevent Flu Preventive | 0.505969 |
| Flu Vaccine Recommendation | 0.657322 |
| Flu Treatment | 0.485735 |
| Influenza Vaccination Clinic | 0.38851 |
| Flu News | 0.415385 |
| Flu Complications | 0.446476 |
| Flu Season Flu | 0.971451 |
| Diagnosis Flu Symptoms | 0.509214 |
| Flu Vaccine Safety | 0.747052 |
| Cell-Based Flu Vaccines | 0.566465 |
| Flu Season Current | 0.534751 |
| Vaccine Virus Selection | 0.299231 |
| Vaccine Effectiveness | 0.325266 |
| Flu Vaccines Work | 0.579262 |
| Influenza Vaccine Doses | 0.551841 |
| Past Flu Seasons | 0.509974 |
| Influenza 2015-2016 Season | 0.398568 |
|
CLICK HERE |